Advertisement
Screener

WINDTREE THERAPEUTICS INC /DE/ (WINT) Gain (Loss) on Disposition of Assets

WINDTREE THERAPEUTICS INC /DE/ Gain (Loss) on Disposition of Assets

WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Gain (Loss) on Disposition of Assets of $9.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-04-03.

Discontinued › Income Statement › Other Income

us-gaap:GainLossOnDispositionOfAssets1 · last filed 2020-04-03

  • WINDTREE THERAPEUTICS INC /DE/ gain (loss) on disposition of assets for the quarter ending 2018-12-31 was $0.00.
  • WINDTREE THERAPEUTICS INC /DE/ gain (loss) on disposition of assets for the quarter ending 2018-09-30 was $0.00.
  • WINDTREE THERAPEUTICS INC /DE/ gain (loss) on disposition of assets for the quarter ending 2016-12-31 was $0.00.
  • WINDTREE THERAPEUTICS INC /DE/ gain (loss) on disposition of assets for the quarter ending 2015-12-31 was $0.00.
  • WINDTREE THERAPEUTICS INC /DE/ gain (loss) on disposition of assets for fiscal 2018 was $9.00K.
  • WINDTREE THERAPEUTICS INC /DE/ gain (loss) on disposition of assets for fiscal 2016 was $16.00K.
  • WINDTREE THERAPEUTICS INC /DE/ gain (loss) on disposition of assets for fiscal 2015 was -$84.00K.
  • WINDTREE THERAPEUTICS INC /DE/ gain (loss) on disposition of assets for fiscal 2014 was $0.00.
Period endGain (Loss) on Disposition of Assets 1 monthGain (Loss) on Disposition of Assets 3 monthGain (Loss) on Disposition of Assets 6 monthGain (Loss) on Disposition of Assets 9 monthGain (Loss) on Disposition of Assets 12 month
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03
$0.00
derived: sum of 2 quarters · filed 2020-04-03
$9.00K
10-K · filed 2020-04-03
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
$9.00K
10-Q · filed 2019-11-14
2018-06-30$9.00K
10-Q · filed 2019-08-14
2016-12-31$16.00K
10-K · filed 2017-03-31
$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-17
$16.00K
10-K · filed 2018-04-17
2016-09-30$16.00K
10-Q · filed 2017-11-14
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31
$0.00
derived: sum of 2 quarters · filed 2017-03-31
$100.00K
derived: sum of 3 quarters · filed 2017-03-31
-$84.00K
10-K · filed 2017-03-31
2015-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
$100.00K
derived: sum of 2 quarters · filed 2016-11-14
-$84.00K
10-Q · filed 2016-11-14
2015-06-30$100.00K
10-K · filed 2016-03-29
-$84.00K
10-Q · filed 2016-08-10
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29
$0.00
derived: sum of 2 quarters · filed 2016-03-29
$0.00
10-K · filed 2016-03-29
2014-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$0.00
10-Q · filed 2015-11-05
2014-06-30$0.00
10-Q · filed 2015-08-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
CURIS INC (CRIS)United States$0.002B-0.05
Silexion Therapeutics Corp (SLXN)$0.001B
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70